Efficacy News and Research

RSS
LegoChem Biosciences and Iksuda Therapeutics expand License Agreement for development of antibody-drug conjugates

LegoChem Biosciences and Iksuda Therapeutics expand License Agreement for development of antibody-drug conjugates

Study: Immune responses may develop against other proteins produced by SARS-CoV-2

Study: Immune responses may develop against other proteins produced by SARS-CoV-2

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

FLASH radiotherapy could revolutionize future tumor treatments

FLASH radiotherapy could revolutionize future tumor treatments

Dual-antibody combination therapies effective against SARS-CoV-2 variants in animal study

Dual-antibody combination therapies effective against SARS-CoV-2 variants in animal study

FDA approves oral pellets to treat children with venous thromboembolism

FDA approves oral pellets to treat children with venous thromboembolism

Study reviews natural drug candidates for potential treatment of COVID-19

Study reviews natural drug candidates for potential treatment of COVID-19

Researchers identify four substances that inhibit SARS-CoV-2 replication in cells

Researchers identify four substances that inhibit SARS-CoV-2 replication in cells

Can a prior rhinovirus infection protect against COVID-19?

Can a prior rhinovirus infection protect against COVID-19?

Can convalescent plasma therapy improve COVID-19 outcomes in patients with hematologic cancers?

Can convalescent plasma therapy improve COVID-19 outcomes in patients with hematologic cancers?

Targeting lung inflammation with cell membrane-based dexamethasone nanodelivery platform

Targeting lung inflammation with cell membrane-based dexamethasone nanodelivery platform

Novel vaccine based on mRNA technology protects against malaria in animal models

Novel vaccine based on mRNA technology protects against malaria in animal models

RIG-1 agonist shows potent antiviral efficacy against SARS-CoV-2 infection

RIG-1 agonist shows potent antiviral efficacy against SARS-CoV-2 infection

Combination of interferon-α and nafamostat inhibits SARS-CoV-2 in vivo

Combination of interferon-α and nafamostat inhibits SARS-CoV-2 in vivo

COVID-19 outbreak in Mauritius dominated by new SARS-CoV-2 variant B.1.1.318

COVID-19 outbreak in Mauritius dominated by new SARS-CoV-2 variant B.1.1.318

Could horse-derived antibody therapy be effective against SARS-CoV-2 variants of concern?

Could horse-derived antibody therapy be effective against SARS-CoV-2 variants of concern?

New computational model simulates the spread and impact of COVID-19 virus

New computational model simulates the spread and impact of COVID-19 virus

Combination of anti-HER2 breast cancer therapy and checkpoint inhibitor provides no benefit

Combination of anti-HER2 breast cancer therapy and checkpoint inhibitor provides no benefit

The SARS-CoV-2 virus and its vaccines pose unique challenges

The SARS-CoV-2 virus and its vaccines pose unique challenges

Regeneron mAb cocktail benefits hospitalized patients with no natural SARS-CoV-2 antibody response

Regeneron mAb cocktail benefits hospitalized patients with no natural SARS-CoV-2 antibody response